Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-04-02 @ 4:55 AM
Study NCT ID:
NCT00113204
Status:
COMPLETED
Last Update Posted:
2008-05-20
First Post:
2005-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma
Sponsor:
Infinity Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IPI-504-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None